Home/Filings/4/A/0001613103-25-000032
4/A//SEC Filing

Pieton Thierry 4/A

Accession 0001613103-25-000032

CIK 0001613103other

Filed

Mar 9, 8:00 PM ET

Accepted

Mar 10, 5:02 PM ET

Size

9.3 KB

Accession

0001613103-25-000032

Insider Transaction Report

Form 4/AAmended
Period: 2025-03-03
Pieton Thierry
EVP & Chief Financial Officer
Transactions
  • Award

    Ordinary Shares

    2025-03-03+4,2424,242 total
  • Award

    Stock Option (Right to Buy)

    2025-03-03+29,57429,574 total
    Exercise: $94.30Exp: 2035-03-03Ordinary Shares (29,574 underlying)
  • Award

    Ordinary Shares

    2025-03-03+26,51230,754 total
Footnotes (3)
  • [F1]Form 4 filed 3/5/2025 reported incorrect vesting information for restricted stock units due to an administrative error. The purpose of this amendment is to correct the vesting description to state: Represents restricted stock units that vest 100% on July 29, 2027.
  • [F2]Form 4 filed 3/5/2025 reported incorrect pricing information for restricted stock units due to an administrative error. The purpose of this amendment is to reflect that restricted stock units were received as a grant, for no consideration.
  • [F3]Form 4 filed 3/5/2025 reported incorrect vesting information for options due to an administrative error. The purpose of this amendment is to correct the vesting description to state: The options are exercisable in four equal annual installments on July 29th of 2025, 2026, 2027 and 2028.

Issuer

Medtronic plc

CIK 0001613103

Entity typeother

Related Parties

1
  • filerCIK 0002056622

Filing Metadata

Form type
4/A
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 5:02 PM ET
Size
9.3 KB